MedTrace Logo

Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II

NCT00247169 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-03-09

No results posted yet for this study

Summary

The investigators want to test whether treatment with a natural progesterone intravaginally increases the cure rate of cervical intraepithelial neoplasia grade I and II.

Conditions

  • Cervical Intraepithelial Neoplasia

Interventions

DRUG

progesterone

Micronized progesterone 400mg 1x daily for 10 days/month from menstrual cycle day 16-25

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Lukas A Hefler, MD · Medical University of Vienna

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2009-04-30
Completion
2010-04-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00247169 on ClinicalTrials.gov